Beverly Hills Private Wealth LLC Has $525,000 Stock Position in MetLife, Inc. $MET

Beverly Hills Private Wealth LLC reduced its position in MetLife, Inc. (NYSE:MET) by 2.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 6,533 shares of the financial services provider’s stock after selling 176 shares during the period. Beverly Hills Private Wealth LLC’s holdings in MetLife were worth $525,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Forvis Mazars Wealth Advisors LLC lifted its position in MetLife by 4.6% during the second quarter. Forvis Mazars Wealth Advisors LLC now owns 22,455 shares of the financial services provider’s stock worth $1,806,000 after acquiring an additional 992 shares during the last quarter. Chicago Partners Investment Group LLC increased its stake in MetLife by 20.8% in the second quarter. Chicago Partners Investment Group LLC now owns 4,525 shares of the financial services provider’s stock valued at $355,000 after acquiring an additional 780 shares during the last quarter. Signature Estate & Investment Advisors LLC increased its stake in MetLife by 3.6% in the second quarter. Signature Estate & Investment Advisors LLC now owns 708,088 shares of the financial services provider’s stock valued at $56,944,000 after acquiring an additional 24,772 shares during the last quarter. Aspiriant LLC increased its stake in MetLife by 15.9% in the second quarter. Aspiriant LLC now owns 3,866 shares of the financial services provider’s stock valued at $311,000 after acquiring an additional 530 shares during the last quarter. Finally, Koshinski Asset Management Inc. increased its stake in MetLife by 14.1% in the second quarter. Koshinski Asset Management Inc. now owns 4,566 shares of the financial services provider’s stock valued at $367,000 after acquiring an additional 565 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts recently issued reports on MET shares. Morgan Stanley lifted their price objective on shares of MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Barclays boosted their target price on shares of MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Jefferies Financial Group boosted their target price on shares of MetLife from $100.00 to $103.00 and gave the stock a “buy” rating in a research note on Monday, August 11th. Piper Sandler cut shares of MetLife from an “overweight” rating to a “neutral” rating and set a $84.00 target price on the stock. in a research note on Friday, September 19th. Finally, UBS Group decreased their target price on shares of MetLife from $94.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, MetLife has a consensus rating of “Moderate Buy” and a consensus price target of $95.18.

MetLife Price Performance

Shares of NYSE:MET opened at $78.78 on Tuesday. The firm has a market cap of $52.39 billion, a PE ratio of 13.35, a price-to-earnings-growth ratio of 0.71 and a beta of 0.86. The firm’s fifty day moving average is $80.27 and its 200-day moving average is $78.17. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52 week low of $65.21 and a 52 week high of $89.05.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing analysts’ consensus estimates of $2.32 by ($0.30). The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.MetLife’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.28 EPS. Sell-side analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be issued a $0.5675 dividend. The ex-dividend date is Tuesday, November 4th. This represents a $2.27 annualized dividend and a yield of 2.9%. MetLife’s payout ratio is presently 38.47%.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.